NCT00625521View on ClinicalTrials.gov

Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions

PHASE2CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

November 30, 2006

Study Completion Date

July 31, 2007

Conditions

Discoid Lupus Erythematosus

Interventions

DRUG

ASF 1096 0.5 % cream applied twice daily

DRUG

Cream vehicle for ASF 1096 cream applied twice daily

Trial Locations (1)

Unknown

Filippa Nyberg, Danderyd Stockholm

Sponsors

Lead Sponsor

Astion Pharma A/S

All Listed Sponsors

lead

Astion Pharma A/S

INDUSTRY

NCT00625521 - Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions | Biotech Hunter | Biotech Hunter